EFNA4 influences the proliferation and migration of HCC cells by promoting EphA2 phosphorylation at Ser897, activating the PIK3R2/GSK3β/β-catenin signaling pathway loop (Lin et al., 2021). Here, GSK3B is linked to hepatocellular carcinoma.